$7.11
-0.10 (-1.39%)
ANGI News2 articles
Quantum Computing Stocks Slip as Investors Seek Tangible Revenue Over Long-Term Potential
Rigetti Computing shares declined alongside peers IonQ and D-Wave Quantum, highlighting investor impatience for revenue growth over technological promises. A new UK quantum funding package failed to lift the sector.
BioCryst Shares Slip on New Hereditary Angioedema Drug Data
BioCryst Pharmaceuticals shares fell premarket following new clinical data for its hereditary angioedema candidate navenibart. The company reaffirmed its 2026 revenue outlook and plans a Phase 3 filing by late 2027.